A detailed history of Northwest Financial Advisors transactions in Organon & Co. stock. As of the latest transaction made, Northwest Financial Advisors holds 264 shares of OGN stock, worth $3,849. This represents 0.0% of its overall portfolio holdings.

Number of Shares
264
Previous 344 23.26%
Holding current value
$3,849
Previous $7.12 Million 29.02%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.65 - $23.03 $1,492 - $1,842
-80 Reduced 23.26%
264 $5.05 Million
Q2 2024

Aug 12, 2024

BUY
$17.45 - $21.96 $575 - $724
33 Added 10.61%
344 $7.12 Million
Q1 2024

May 09, 2024

BUY
$13.78 - $18.8 $41 - $56
3 Added 0.97%
311 $5.83 Million
Q4 2023

Feb 07, 2024

BUY
$10.95 - $17.32 $3,372 - $5,334
308 New
308 $4.43 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Northwest Financial Advisors Portfolio

Follow Northwest Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Financial Advisors with notifications on news.